Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluciclovine PET in Newly Diagnosed Glioblastoma
NCT04840069Phase 2Unknown
- Sponsor
- St. Joseph's Hospital and Medical Center
- Start
- Jun 2021
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fluciclovine f 18 in glioblastoma (GBM), sponsored by St. Joseph's Hospital and Medical Center. Status: unknown.
02
Drugs
fluciclovine f 18
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT04840069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04840069.